- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02270047
SATIN The Acute Effect of Orange Nectar With NAXUS Fibre Made by Novel Processing on Satiety and Satiation (SATIN)
March 16, 2015 updated by: Anders Mikael Sjödin, MD, PHD ass professor, University of Copenhagen
A 4 week double blinded parallel design with an intervention condition and a control condition will be employed.
After having completed screening procedure and a baseline test day, participants will be randomized to either intervention or control condition.
In the following 4 weeks, the participants will have to consume the distributed food product daily before completing another test day.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 1958
- Department of Nutrition Exercise and Sports
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Participants who have provided written informed consent
- BMI between 23.0-27.9 kg/m2
- Regular breakfast eaters (eating breakfast ≥ 4 times a week)
- Regular menstrual periods
Exclusion Criteria:
- Significant health problems as judged by the investigator
- Taking any medication or supplements known to affect appetite or body weight within the past month and/or during the study as judged by the investigator
- Pregnant, planning to become pregnant within the next 4 weeks or breastfeeding
- History of anaphylaxis to food
Any known food allergies or food intolerance, specifically the below listed:
- Cereals containing gluten, namely: wheat, rye, barley, oats, spelt, kamut or their hybridised strains, and products thereof;
- Crustaceans and products thereof;
- Eggs and products thereof;
- Fish and products thereof;
- Peanuts and products thereof;
- Soybeans and products thereof;
- Milk and products thereof (including lactose);
- Nuts, namely: almonds (Amygdalus communis L.), hazelnuts (Corylus avellana), walnuts (Juglans regia), cashews (Anacardium occidentale), pecan nuts (Carya illinoinensis (Wangenh.) K. Koch), Brazil nuts (Bertholletia excelsa), pistachio nuts (Pistacia vera), macadamia or Queensland nuts (Macadamia ternifolia), and products thereof, except for nuts used for making alcoholic distillates including ethyl alcohol of agricultural origin;
- Celery and products thereof;
- Mustard and products thereof;
- Sesame seeds and products thereof;
- Sulphur dioxide and sulphites;
- Lupin
- Molluscs
- Smoking, smoking cessation within the past 3 months or nicotine use (electronic cigarettes)
- Self-reporting currently dieting or having lost/gained significant amount of weight (±3 kg) in the previous 3 months
- Significant changes in physical activity patterns in the past 4 weeks or intention to change during the study as judged by the investigator
- Significant change in diet in the past 4 weeks or intention to change the diet during the study as judged by the investigator
- Use of systemic or local treatment likely to interfere with evaluation of the study parameters as judged by the investigator
- Participants who work in appetite or feeding related areas
- Participants not able to comply with the study protocol
- Post-menopausal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: A
Orange nectar with NAXUS fibre, 5g/100mL
|
|
PLACEBO_COMPARATOR: B
Orange nectar
|
Orange nectar
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
AD libitum energy intake
Time Frame: week0, week 4
|
week0, week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAS score for appetite sensation
Time Frame: Week 0, week 4
|
Perceptions of hunger, fullness, desire to eat, prospective consumption will be assessed using 100 mm VAS scales
|
Week 0, week 4
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Eating behaviour
Time Frame: week 0 week 4
|
Eating behaviour will be assessed by the binge eating scale from Gormally et al. 1982, the Control og Eating questionnaire by Hill et al. 1991, the Power og food scale by Lowe et al 2009, and the Three Factor Eating Questionnaire by Stunkard and Messick, 1985
|
week 0 week 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Graham Finlayson, Ass Prof, University of Liverpool
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (ACTUAL)
March 1, 2015
Study Completion (ACTUAL)
March 1, 2015
Study Registration Dates
First Submitted
October 13, 2014
First Submitted That Met QC Criteria
October 20, 2014
First Posted (ESTIMATE)
October 21, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
March 17, 2015
Last Update Submitted That Met QC Criteria
March 16, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- B315
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Appetite
-
University of BirminghamCompletedNeural Responses | Appetite Hormones | Subjective Appetite SensationsUnited Kingdom
-
United States Army Research Institute of Environmental...Completed
-
University of BirminghamUniversity of OxfordCompleted
-
InQpharm GroupCompletedAppetite Regulation | Energy Intake | Appetite SuppressionGermany
-
Universitaire Ziekenhuizen KU LeuvenUnknownAppetite RegulationBelgium
-
Unilever R&DCompletedSatiety | AppetiteUnited Kingdom
-
Unilever R&DCompleted
-
Pennington Biomedical Research CenterEgg Nutrition CenterCompleted
-
Oxford Brookes UniversityCompleted
Clinical Trials on Orange Nectar with fibre
-
University of RochesterCompletedAcne Scars - Mixed Atrophic and HypertrophicUnited States
-
Hasselt UniversityHochschule Geisenheim UniversityUnknown
-
Société des Produits Nestlé (SPN)Recruiting
-
University of CologneFresenius KabiCompletedAcute Renal FailureGermany
-
University of TorontoSaskatchewan Pulse Growers; Pulse CanadaCompleted
-
University of HohenheimCompleted
-
University of Nevada, RenoUnited States Department of Agriculture (USDA); Sierra Nevada Nephrology Consultants...Enrolling by invitationHyperkalemia | Chronic Kidney Disease Requiring Chronic DialysisUnited States
-
Molnlycke Health Care ABCompletedVenous Leg UlcerGermany, France, Czechia, Denmark, Poland, Sweden
-
University of GlasgowActive, not recruiting
-
Hacettepe UniversityCompletedNausea | Vomiting | Anxiety State